- Home
- MYNZ
MYNZ
Mainz Biomed N.V.
as of 12-17-2025 3:09pm EST
$1.11
+$0.10
+10.50%
Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.
Chart Type:
Time Range:
| Founded: | 2021 | Country: | Germany |
| Employees: | N/A | City: | N/A |
| Market Cap: | 8.8M | IPO Year: | 2021 |
| Target Price: | $14.00 | AVG Volume (30 days): | 197.9K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -8.39 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.92 - $8.20 | Next Earning Date: | 12-29-2025 |
| Revenue: | $659,935 | Revenue Growth: | -28.05% |
| Revenue Growth (this year): | -0.28% | Revenue Growth (next year): | 5.03% |
Latest Mainz Biomed N.V. News
MYNZ Breaking Stock News: Dive into MYNZ Ticker-Specific Updates for Smart Investing
Compare MYNZ vs Leading Stocks
See how MYNZ stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "MYNZ Mainz Biomed N.V. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.